The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.


Journal

Advances in nutrition (Bethesda, Md.)
ISSN: 2156-5376
Titre abrégé: Adv Nutr
Pays: United States
ID NLM: 101540874

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 27 07 2018
accepted: 10 10 2018
pubmed: 6 2 2019
medline: 1 4 2020
entrez: 6 2 2019
Statut: ppublish

Résumé

Cancer is the second leading cause of mortality worldwide. The role of unresolved inflammation in cancer progression and metastasis is well established. Platelet-activating factor (PAF) is a key proinflammatory mediator in the initiation and progression of cancer. Evidence suggests that PAF is integral to suppression of the immune system and promotion of metastasis and tumor growth by altering local angiogenic and cytokine networks. Interactions between PAF and its receptor may have a role in various digestive, skin, and hormone-dependent cancers. Diet plays a critical role in the prevention of cancer and its treatment. Research indicates that the Mediterranean diet may reduce the incidence of several cancers in which dietary PAF inhibitors have a role. Dietary PAF inhibitors such as polar lipids have demonstrated inhibitory effects against the physiological actions of PAF in cancer and other chronic inflammatory conditions in vitro and in vivo. In addition, experimental models of radiotherapy and chemotherapy demonstrate that inhibition of PAF as adjuvant therapy may lead to more favorable outcomes. Although promising, there is limited evidence on the potential benefits of dietary PAF inhibitors on cancer prevention or treatment. Therefore, further extensive research is required to assess the effects of various dietary factors and PAF inhibitors and to elucidate the mechanisms in prevention of cancer progression and metastasis at a molecular level.

Identifiants

pubmed: 30721934
pii: S2161-8313(22)01295-9
doi: 10.1093/advances/nmy090
pmc: PMC6370273
doi:

Substances chimiques

Platelet Activating Factor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-164

Références

Oncotarget. 2016 Apr 12;7(15):20788-800
pubmed: 26959112
Cancer Chemother Pharmacol. 2011 Sep;68(3):713-20
pubmed: 21153821
J Dairy Sci. 2017 Jun;100(6):4197-4212
pubmed: 28342603
Immunology. 2014 Sep;143(1):21-32
pubmed: 24628121
J Nutr. 2010 Oct;140(10):1774-80
pubmed: 20739445
J Hepatol. 2007 Jul;47(1):83-92
pubmed: 17399847
Cancer Chemother Pharmacol. 2006 Feb;57(3):295-300
pubmed: 16032431
Int Arch Allergy Immunol. 2004 May;134(1):17-28
pubmed: 15051936
Annu Rev Nutr. 2015;35:425-49
pubmed: 25974696
Heliyon. 2017 Jan 09;3(1):e00227
pubmed: 28119955
Cancer Res. 2004 Nov 15;64(22):8405-10
pubmed: 15548711
J Biol Chem. 2005 Oct 21;280(42):35448-57
pubmed: 16115894
Metabolism. 2012 Mar;61(3):325-34
pubmed: 21944262
Cancer Metastasis Rev. 2007 Dec;26(3-4):359-71
pubmed: 17721743
J Lipid Res. 2003 Feb;44(2):380-7
pubmed: 12576520
Nutr Cancer. 2016 Oct;68(7):1234-46
pubmed: 27472445
Hepatogastroenterology. 2009 Mar-Apr;56(90):481-4
pubmed: 19579625
J Immunol. 1995 Jun 15;154(12):6492-501
pubmed: 7539022
Cancer Res. 1996 Jun 1;56(11):2662-5
pubmed: 8653713
Lipids Health Dis. 2011 Nov 16;10:213
pubmed: 22087726
Infect Disord Drug Targets. 2009 Aug;9(4):390-9
pubmed: 19689381
Mediators Inflamm. 2007;2007:27683
pubmed: 17710109
J Invest Dermatol. 2010 May;130(5):1428-37
pubmed: 19829299
Int J Clin Exp Pathol. 2015 Jan 01;8(1):432-40
pubmed: 25755731
Biochim Biophys Acta. 1995 Feb 9;1254(3):231-49
pubmed: 7857964
Neuroscience. 2018 May 1;377:105-113
pubmed: 29522856
Biochim Biophys Acta. 1997 Sep 4;1348(1-2):111-6
pubmed: 9370322
Crit Rev Clin Lab Sci. 2003 Dec;40(6):643-72
pubmed: 14708958
Cancer Res. 2002 Mar 15;62(6):1809-14
pubmed: 11912159
Meat Sci. 2010 Jan;84(1):1-13
pubmed: 20374748
Nutrients. 2018 May 12;10(5):
pubmed: 29757226
Mini Rev Med Chem. 2006 Aug;6(8):945-51
pubmed: 16918500
World J Gastroenterol. 2006 May 7;12(17):2773-8
pubmed: 16718768
Am J Pathol. 2000 Nov;157(5):1713-25
pubmed: 11073830
Clin Exp Metastasis. 2000;18(1):89-96
pubmed: 11206844
Int J Cancer. 2002 Aug 20;100(6):654-61
pubmed: 12209602
Eur J Clin Nutr. 2018 Jan;72(1):30-43
pubmed: 28488692
Pharm Res. 2008 Sep;25(9):2097-116
pubmed: 18626751
Nutr Cancer. 2014;66(5):810-7
pubmed: 24847911
Free Radic Biol Med. 2006 Feb 15;40(4):581-90
pubmed: 16458188
Nutr Cancer. 2006;54(1):102-10
pubmed: 16800778
World J Gastroenterol. 2006 Jan 28;12(4):539-45
pubmed: 16489665
Oncogene. 2015 Oct 1;34(40):5114-27
pubmed: 25639872
Br J Cancer. 2013 Feb 19;108(3):486-92
pubmed: 23299528
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Food Chem. 2014 Dec 15;165:50-9
pubmed: 25038648
Neuropathol Appl Neurobiol. 2006 Dec;32(6):674-8
pubmed: 17083481
BMJ. 2008 Sep 11;337:a1344
pubmed: 18786971
Crit Rev Oncol Hematol. 2017 Apr;112:190-197
pubmed: 28325259
Nutr Clin Pract. 2010 Dec;25(6):634-40
pubmed: 21139128
Br J Cancer. 2015 Mar 3;112(5):943-7
pubmed: 25647015
Enzymes. 2015;38:1-22
pubmed: 26612643
Trends Cardiovasc Med. 2001 Apr-May;11(3-4):139-42
pubmed: 11686003
Prog Lipid Res. 2011 Jan;50(1):104-14
pubmed: 20970453
N Engl J Med. 2007 May 24;356(21):2131-42
pubmed: 17522398
Physiol Rep. 2015 Mar;3(3):
pubmed: 25802360
J Bioenerg Biomembr. 2016 Apr;48(2):153-68
pubmed: 25620271
Biosci Biotechnol Biochem. 1999 Feb;63(2):298-301
pubmed: 10192909
Curr Cancer Drug Targets. 2007 Aug;7(5):459-64
pubmed: 17691905
Cancer Res. 2006 May 1;66(9):4681-6
pubmed: 16651419
Lung Cancer. 2001 Aug-Sep;33(2-3):195-202
pubmed: 11551414
J Inorg Biochem. 2013 Mar;120:63-73
pubmed: 23318288
Diabetologia. 2013 Nov;56(11):2405-13
pubmed: 23975324
J Biochem. 2002 Jun;131(6):773-9
pubmed: 12038971
Nutr Metab Cardiovasc Dis. 2006 Apr;16(3):174-85
pubmed: 16580585
Food Chem. 2016 Dec 1;212:695-702
pubmed: 27374586
Int J Oncol. 2016 Jul;49(1):181-8
pubmed: 27176648
Curr Pharm Des. 2001 Nov;7(16):1615-26
pubmed: 11562302
Am J Pathol. 2015 Apr;185(4):888-96
pubmed: 25655028
Nutr Cancer. 2017 Aug-Sep;69(6):952-961
pubmed: 28742384
Eur J Cancer Prev. 2013 Jan;22(1):90-5
pubmed: 22644232
Inflamm Bowel Dis. 2010 Apr;16(4):593-603
pubmed: 19714753
Eur J Nutr. 2015 Feb;54(1):25-34
pubmed: 24639073
J Invest Dermatol. 1990 Nov;95(5):530-6
pubmed: 2230216
Eur J Endocrinol. 2005 Jul;153(1):31-40
pubmed: 15994743
Br J Nutr. 2012 Jul;108(2):327-33
pubmed: 22114792
Br J Cancer. 2008 Jul 8;99(1):191-5
pubmed: 18594542
J Exp Med. 2002 Jan 21;195(2):171-9
pubmed: 11805144
Sci Transl Med. 2014 Apr 23;6(233):233re2
pubmed: 24760190
EMBO J. 1997 Jan 2;16(1):133-42
pubmed: 9009274
Foods. 2018 Mar 01;7(3):
pubmed: 29494487
Biochem Pharmacol. 2006 May 14;71(10):1479-87
pubmed: 16580641
Mar Drugs. 2018 May 23;16(6):
pubmed: 29882848
Biomark Cancer. 2016 Apr 26;8(Suppl 1):27-35
pubmed: 27147897
J Agric Food Chem. 2002 Apr 24;50(9):2684-94
pubmed: 11958642
Lancet. 1978 May 13;1(8072):1051-2
pubmed: 76975
J Biol Chem. 1990 Oct 15;265(29):17381-4
pubmed: 2170377
BMC Gastroenterol. 2004 Dec 29;4:33
pubmed: 15625005
Genes Dis. 2015 Sep;2(3):255-260
pubmed: 29354667
Br J Cancer. 2014 Jul 29;111(3):515-24
pubmed: 24921917
Biochem Biophys Res Commun. 2007 May 4;356(2):323-8
pubmed: 17367763
J Leukoc Biol. 2014 Jan;95(1):139-48
pubmed: 24009177
J Biol Chem. 2007 Mar 2;282(9):6532-9
pubmed: 17182612
J Clin Invest. 1991 Dec;88(6):2106-16
pubmed: 1661298
PLoS One. 2015 Mar 24;10(3):e0120143
pubmed: 25803864
J Agric Food Chem. 2001 Nov;49(11):5186-93
pubmed: 11714301
Br J Nutr. 2007 Oct;98 Suppl 1:S127-32
pubmed: 17922950
Mediators Inflamm. 2012;2012:175408
pubmed: 22570511
Expert Opin Pharmacother. 2006 Oct;7(14):1989-2001
pubmed: 17020424
Semin Oncol. 2004 Apr;31(2 Suppl 7):12-21
pubmed: 15252926
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Anim Sci J. 2013 Mar;84(3):264-71
pubmed: 23480708
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Drugs Today (Barc). 2003 Jun;39(6):451-68
pubmed: 12944997
J Med Food. 2006 Fall;9(3):356-62
pubmed: 17004898
Eur J Clin Invest. 1996 Jan;26(1):53-8
pubmed: 8682156
Free Radic Biol Med. 2012 Jul 15;53(2):260-70
pubmed: 22580337
Nutrients. 2017 Sep 26;9(10):
pubmed: 28954418
Public Health Nutr. 2014 Dec;17(12):2769-82
pubmed: 24476641
Am J Clin Nutr. 2005 Feb;81(2):341-54
pubmed: 15699220
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2413-8
pubmed: 16214925
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Prog Lipid Res. 2003 Mar;42(2):93-114
pubmed: 12547653
J Lipids. 2013;2013:178910
pubmed: 23984075
Breast Cancer Res Treat. 2010 Aug;123(1):51-8
pubmed: 19902352
Adv Exp Med Biol. 1996;416:59-63
pubmed: 9131127
Front Oncol. 2015 Jul 08;5:128
pubmed: 26217583
Cancer Growth Metastasis. 2014 Jun 19;7:27-32
pubmed: 25002816
J Clin Invest. 1995 Nov;96(5):2322-30
pubmed: 7593619
Prostaglandins Other Lipid Mediat. 2017 May;130:23-29
pubmed: 28323197
Biomed Pharmacother. 2007 Dec;61(10):640-58
pubmed: 18055160
Molecules. 2017 Nov 14;22(11):
pubmed: 29135918
BMC Cancer. 2010 May 13;10:200
pubmed: 20465821
J Agric Food Chem. 2000 Dec;48(12):6372-9
pubmed: 11312810
Int J Cancer. 2007 Dec 1;121(11):2373-80
pubmed: 17893866
Prog Lipid Res. 2016 Jul;63:14-27
pubmed: 27073146
Br J Cancer. 2014 Sep 23;111(7):1454-62
pubmed: 25101568
Pigment Cell Melanoma Res. 2009 Jun;22(3):257-67
pubmed: 19368690
J Immunol. 2011 Jan 1;186(1):25-31
pubmed: 21098222
J Pharmacol Exp Ther. 1997 Jan;280(1):114-21
pubmed: 8996188
Nutr Res. 2008 Sep;28(9):635-40
pubmed: 19083470
Oncogene. 2003 Oct 16;22(46):7222-4
pubmed: 14562051
BMJ. 2018 Feb 14;360:k322
pubmed: 29444771
Carcinogenesis. 2012 Mar;33(3):694-701
pubmed: 22223848
J Agric Food Chem. 2007 Jan 10;55(1):80-9
pubmed: 17199317
Neoplasma. 2014;61(3):309-17
pubmed: 24824933
Prostaglandins Other Lipid Mediat. 2002 Sep;70(1-2):209-26
pubmed: 12428690
Am J Pathol. 1998 Nov;153(5):1589-96
pubmed: 9811351
Eur J Clin Invest. 1999 Sep;29(9):802-9
pubmed: 10469169
Anticancer Res. 2008 Nov-Dec;28(6A):3631-5
pubmed: 19189644
Biochimie. 2010 Jun;92(6):692-7
pubmed: 20167241
Nat Rev Cancer. 2004 Mar;4(3):206-15
pubmed: 14993902
J Nutr. 2012 Sep;142(9):1672-8
pubmed: 22810987
Photochem Photobiol. 2010 Jul-Aug;86(4):949-54
pubmed: 20492565
Annu Rev Biochem. 2000;69:419-45
pubmed: 10966465
Nutr Metab Cardiovasc Dis. 2010 Dec;20(10):740-7
pubmed: 19748252
ChemMedChem. 2018 Dec 6;13(23):2484-2487
pubmed: 30381909
Inflamm Res. 1996 Nov;45(11):546-9
pubmed: 8951505
Front Oncol. 2018 Feb 05;8:10
pubmed: 29459885
Int J Cancer. 2005 Jan 20;113(3):503-5
pubmed: 15455343
Biosci Rep. 2017 Nov 15;37(6):
pubmed: 29026007
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1091-4
pubmed: 14578148
Arch Biochem Biophys. 2003 Nov 15;419(2):129-38
pubmed: 14592456
J Gastric Cancer. 2012 Sep;12(3):164-72
pubmed: 23094228
J Biol Chem. 2008 Apr 25;283(17):11097-106
pubmed: 18285344
Biochem Pharmacol. 2004 Sep 15;68(6):1071-80
pubmed: 15313403
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
Nutrition. 1999 Jun;15(6):523-6
pubmed: 10378216
Neurochem Res. 2000 May;25(5):705-13
pubmed: 10905633
Oncology (Williston Park). 2009 Apr 15;23(4):380-5
pubmed: 19476269
Prostaglandins Leukot Essent Fatty Acids. 1994 Jan;50(1):1-28
pubmed: 8146205
Int J Cancer. 2014 Jun 15;134(12):2935-41
pubmed: 24259274
World J Gastroenterol. 2016 May 28;22(20):4794-801
pubmed: 27239106
Annu Rev Nutr. 2017 Aug 21;37:293-320
pubmed: 28826375
Fitoterapia. 2013 Jan;84:180-201
pubmed: 23160091
Bioinorg Chem Appl. 2017;2017:6947034
pubmed: 28458618
Eur J Nutr. 2017 Jun;56(4):1485-1492
pubmed: 26936842
J Biol Chem. 1998 Jul 24;273(30):18891-7
pubmed: 9668065
Lipids Health Dis. 2017 Jun 2;16(1):104
pubmed: 28578704
Mutat Res. 2004 Jul 13;551(1-2):29-42
pubmed: 15225579
Cardiovasc Drugs Ther. 2009 Feb;23(1):73-83
pubmed: 18949548
J Immunol. 2004 May 15;172(10):6330-5
pubmed: 15128823
J Agric Food Chem. 2000 Apr;48(4):1234-8
pubmed: 10775377
Nutrition. 2017 Nov - Dec;43-44:83-88
pubmed: 28935150
Mediators Inflamm. 2004 Feb;13(1):53-4
pubmed: 15203567
Biomed Pharmacother. 2002 Sep;56(7):317-24
pubmed: 12418578
Oncogenesis. 2017 Jan 30;6(1):e296
pubmed: 28134937
Cancer Res. 1996 Nov 1;56(21):4936-41
pubmed: 8895747
Eur J Cancer Prev. 2002 Apr;11(2):193-7
pubmed: 11984139
Support Care Cancer. 2010 Feb;18(2):159-70
pubmed: 19404684
Clin Nutr. 2017 Dec;36(6):1457-1464
pubmed: 27931879
Oncol Rep. 2016 Jan;35(1):179-88
pubmed: 26531049
PLoS One. 2013;8(3):e57937
pubmed: 23516420
Diabetes Res Clin Pract. 2006 Apr;72(1):33-41
pubmed: 16236380
Am J Epidemiol. 2012 Dec 15;176(12):1185-92
pubmed: 23186748

Auteurs

Ronan Lordan (R)

Department of Biological Sciences, University of Limerick, Limerick, Ireland.

Alexandros Tsoupras (A)

Department of Biological Sciences, University of Limerick, Limerick, Ireland.

Ioannis Zabetakis (I)

Department of Biological Sciences, University of Limerick, Limerick, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH